Madrigal Pharmaceuticals Appoints Dr. Michael R. Charlton as SVP of Clinical Development
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) has announced the appointment of Dr. Michael R. Charlton as Senior Vice President of Clinical Development, effective October 1, 2024. This key addition …
Madrigal Pharmaceuticals Appoints Dr. Michael R. Charlton as SVP of Clinical Development Read More